Sirukumab, a rheumatoid arthritis treatment that has performed well in recent studies, is now awaiting approval in both the United States and Europe.
The FDA today approved its fourth biosimilar, a tumor necrosis factor inhibitor similar to adalimumab.
Peter A. McCullough, MD, and Nicolaas Deutz, MD, PhD, highlight the role of amino acids, protein, and B-hydroxy B-methylbutyrate in rebuilding muscle mass for patients with sarcopenia.
Nicolaas Deutz, MD, PhD, and Peter A. McCullough, MD, discuss the importance of the role of protein in treating malnutrition and sarcopenia.
Using older mice, researchers looking for ways to prevent stroke found a protective effect in bexaratone. The age of the mice is significant in that most studies are done on young animals and findings might not apply to mice that have aged.
Peter Salgo, MD; Milton Packer, MD; Scott Solomon, MD; and John R. Teerlink, MD, remark on the appropriateness and benefits of treating patients with heart failure with an angiotensin receptor/neprilysin inhibitor (ARNI) (ie, valsartan/sacubitril) rather than with an angiotensin-converting enzyme (ACE) inhibitor.
“Acute alcohol consumption has long been linked to development of AF. In the Framingham, Copenhagen, and Women's Health Studies, chronic alcohol consumption, especially 2 or more drinks per day, is associated with up to 30% higher risk for incident AF,” the study authors wrote in the Journal of the American Heart Association.
One year after beginning Lucentis treatment for diabetic macular edema, the group who had a decrease in visual acuity also had the greatest decrease in HbA1c level.
Nearly half of the UK's asthma deaths could likely have been prevented, researchers there found.